MENU

EQ Equillium Forecast, Technical & Fundamental Analysis

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology
EQ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
EQ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EQ is expected to report earnings to fall ∞% to -29 cents per share on March 26

Equillium EQ Stock Earnings Reports
Q4'24
Est.
$-0.29
Q3'24
Missed
by $0.29
Q2'24
Beat
by $0.16
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.10
The last earnings report on November 13 showed earnings per share of 0 cents, missing the estimate of 28 cents. With 30.10K shares outstanding, the current market capitalization sits at 24.24M.
A.I. Advisor
published General Information

General Information

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2223 Avenida De La Playa
Phone
+1 858 240-1200
Employees
44
Web
https://www.equilliumbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

EQ and Stocks

Correlation & Price change

A.I.dvisor tells us that EQ and IMNM have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EQ and IMNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
-12.33%
IMNM - EQ
32%
Poorly correlated
-3.88%
MTNB - EQ
30%
Poorly correlated
-10.65%
AUTL - EQ
27%
Poorly correlated
-8.51%
GLPG - EQ
25%
Poorly correlated
+1.23%
BLRX - EQ
24%
Poorly correlated
+0.88%
More

Groups containing EQ

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
-12.33%
drugs
theme (254 stocks)
20%
Poorly correlated
-1.67%
immune
theme (11 stocks)
15%
Poorly correlated
-3.03%
biotechnology
theme (238 stocks)
8%
Poorly correlated
-1.76%